Asymptomatic oral carriage of Candida albicans in patients with HIV infection

Clinical and Investigative Medicine

Volumn 20, Issue 2, 1997, Pages 85-93

  Fong, Ignatius W ^a   Laurel, Manuel ^a   Burford Mason, Aileen ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD GROUP TYPING; CANADA; CANDIDA ALBICANS; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALIVA ANALYSIS; THRUSH;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BLOOD GROUPING AND CROSSMATCHING; CANDIDIASIS, ORAL; CARRIER STATE; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0030991437     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bodey G, editor. Candidiasis: a growing concern. Am J Med 1989;77(Suppl 4D):1-48.
2. Meunier F. Candidiasis. Eur J Clin Microbiol Infect Dis 1989;8:438-58.
3. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
4. Imam N, Carpenter CC, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal Candida infection in HIV-seropositive women. Am J Med 1990;89:142-6.
5. Feigal DW, Katz MH, Greenspan D, Westenhouse J, Winkelstein W Jr, Long W, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991;5:519-25.
6. Moss AR. Predicting who will progress to AIDS. BMJ 1988;297:1067-8.
7. Schonheyder G, Melbye M, Biggar RJ, Ebbesen P, Neuland CY, Stenderup A. Oral yeast flora and antibodies to Candida albicans in homosexual men. Mykosen 1984;27:539-44.
8. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988;239:617-22.
9. Smith PD, Kujoshi O, Masur H, Lane HC, Fauci AS, Wahl SM. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest 1984;74:2121-8.
10. Roy S, Wainberg MA. Role of mononuclear phagocyte system in the development of acquired immunodeficiency syndrome. J Leukoc Biol 1988;43:91-7.
11. Lehrer RJ. The fungicidal mechanisms of human monocytes. I. Evidence of myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest 1975;55:338-46.
12. Marodi L, Korchak HM, Johnston RB. Mechanisms of host defence against Candida species. I. Phagocytosis by monocytes and monocyte derived macrophages. J Immunol 1991;146:2783-9.
13. Fetter A, Partisani M, Koenig M, Kremer M, Lang JM. Asymptomatic oral Candida albicans carriage in HIV-infection: frequency and predisposing factors. J Oral Pathol Med 1993;22:57-9.
14. Felix DH, Wray D. The prevalence of oral candidiasis in HIV-infected individuals and dental attenders in Edinburgh. J Oral Pathol Med 1993;22:418-20.
15. Burford-Mason AP, Weber JC, Willloughby JM. Oral carriage of Candida albicans, ABO blood group and secretor status in healthy subjects. J Med Vet Mycol 1988;26:49-56.
16. Burford-Mason AP, Willoughby JM, Weber JC. Association between gastrointestinal tract carriage of Candida blood group O, and non-secretion of blood group antigens in patients with peptic ulcer disease. Dig Dis Sci 1993;38:1453-8.
17. Samaranyake LP. Oral mycosis in HIV infection. Oral Surg Oral Med Oral Pathol 1992;73:171-80.
18. Zhou B, Guo JY, Wang CX, Chen J. The rapid determination of the ABO blood group from body fluids (or stains) by dot enzyme-linked immunosorbent assay (dot-ELISA) using enzyme-labeled monoclonal antibodies. J Forensic Sci 1990;35(5):1125-32.
19. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-3.
20. Wade JC, Schimpff SE. Epidemiology and prevention of Candida infections. In: Bodley GP, Fainstein V, editors. Candidiasis. New York: Raven Press; 1985:111-33.
21. Clamp J. The relationship between the immune system and mucus in the protection mucous membranes. Biochem Soc Trans 1984;12:754-6.
22. Blackwell CC, Thom SM, Weir DM, Kinane DF, Johnstone FD. Host parasite interactions underlying non-secretion of blood group antigens and susceptibility to infections by Candida albicans. In: Lark DL, editor. Protein-carbohydrate interactions in biological systems. London (UK): Academic Press; 1986:231-3.
23. Arendorf TM, Walker DM. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980;25:1-10.
24. Hauman CH, Thompson IO, Theurissen F, Wolfaardt P. Oral carriage of Candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol 1993;75:570-2.
25. Torssander J, Morfeldt-Manson L, Biberfeld G, Karlsson A, Putkonen PO, Wasserman J. Oral Candida albicans in HIV infection. Scand J Infect Dis 1987;19:291-5.
26. De Bernardis F, Boccanera M, Rainaldi L, Guerra CE, Quinti I, Cassone A. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. Eur J Epidemiol 1992;8:362-7.
27. Hamilton JN, Thompson SH, Scheidt MJ, McQuade MJ, Van Dyke T, Plowman K. Correlation of subclinical candidal colonization of the dorsal tongue surface with the Walter Reed staging scheme for patients infected with HIV-I. Oral Surg Oral Med Oral Pathol 1992;73:47-51.
28. Thurmond JM, Brown AT, Sims RE, Ferretti GA, Raybould TP, Lillich TT, et al. Oral Candida albicans in bone marrow transplant patients given oral chlorhexidene rinses: occurrences and susceptibilities to the agent. Oral Surg Oral Med Oral Pathol 1991;72:291-5.